-
-
-
-
-
-
-
Aileron Therapeutics (ALRN) Announces CEO Change
-
-
-
-
-
-
-
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
-
-
-
-
-
-
-
Aileron Therapeutics (ALRN) CEO Resigns
-
-
1,154,835 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

